Article
Profiling cancer testis antigens in non–small-cell lung cancer
6 Jul 2016
Abstract excerpt
Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA landscape of non-small-cell lung cancer (NSCLC), we compared RNAseq data from 199 NSCLC tissues to the normal transcriptome of 142 samples from 32 different normal organs. Of 232 CTAs currently annotated in the Caner Testis Database (CTdatabase), 96 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
